Back to Results
First PageMeta Content
Melanoma / Organochlorides / Organofluorides / Sulfonamides / Vemurafenib / BRAF / Ipilimumab / Dacarbazine / End point of clinical trials / Medicine / Chemistry / Oncology


Microsoft WordDabrafenib GSK PSD March 13 final...docx
Add to Reading List

Document Date: 2014-10-01 21:56:23


Open Document

File Size: 94,43 KB

Share Result on Facebook

Company

GlaxoSmithKline Australia Pty Ltd / /

Country

Australia / /

Currency

USD / /

IndustryTerm

Therapies for advanced melanoma / treatment of advanced or metastatic melanoma / study protocols / /

MedicalCondition

melanoma / cut / III disease / Proposed Therapy Melanomas / squamous cell carcinoma / aggressive and invasive disease / disease / brain metastases / Stable disease / cutaneous squamous cell carcinoma / metastasis / progressive disease / IV melanoma / malignant tumours / cutaneous squamous cell carcinomas / Advanced melanoma / Severe neutropenia / metastatic melanoma / /

MedicalTreatment

radiotherapy / surgery / radiation / /

Organization

World Health Organization / Listing Requested and PBAC’s View Authority / /

Position

author / /

Product

dacarbazine / /

Technology

radiation / pharmacogenetics / study protocols / /

SocialTag